MarketWatch Automation
Shares of Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +0.51% advanced 1.16% to $72.09 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.47% falling 0.14% to 4,670.29 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.76% falling 0.45% to 36,068.87. The stock's rise snapped a seven-day losing streak. Gilead Sciences Inc. closed $2.03 below its 52-week high ($74.12), which the company achieved on December 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.91% fell 0.49% to $173.09, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.83% rose 2.58% to $82.37, and AbbVie Inc. /zigman2/quotes/202428675/composite ABBV -0.38% rose 1.12% to $136.39. Trading volume (10.3 M) eclipsed its 50-day average volume of 7.2 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
GILD
Add to watchlist
DJIA
Add to watchlist
JNJ
Add to watchlist
MRK
Add to watchlist
ABBV
